Reza Mehrazin

Also affiliated with Tisch Hospital, Icahn School of Medicine at Mount Sinai

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial”.

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02568-1

N/A

5.2DataRank · unranked

135 citations

Siamak Daneshmand, Sudeh Izadmehr, Edgar Gonzalez‐Kozlova, Kevin Chan, Sara Lewis +35 more

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer

Cancer Cell(2022)10.1016/j.ccell.2022.08.005

N/A

0.734DataRank · unranked

132 citations

John P. Sfakianos, Daniel Ranti, Jorge Daza, Christine Bieber, Andrew Charap +46 more

Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer

European Urology Oncology(2025)10.1016/j.euo.2024.07.001

N/A

0.542DataRank · unranked

36 citations

Arnab Basu, George Laliotis, Shivaram Cumarasamy, Jordan M. Rich, Ajitha Kommalapati +22 more

Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer

International Journal of Molecular Sciences(2023)10.3390/ijms241914713

N/A

0.385DataRank · unranked

12 citations

Meredith Mihalopoulos, Laura Zuluaga, Jordan Rich, Teja Ganta, Reza Mehrazin +7 more

NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.04.482960

N/A

0.104DataRank · unranked

1 citations

John P. Sfakianos, Jorge Daza, Andrew Charap, Christian Hammer, Romain Banchereau +42 more

The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic

Frontiers in Oncology(2021)10.3389/fonc.2021.734963

N/A

0DataRank · unranked

7 citations

Dara Lundon, Nihal Mohamed, Andrew Katims, Vaibhav G. Patel, Benjamin Eilender +11 more

Novel signatures of prostate cancer progression and therapeutic resistance

Expert Opinion on Therapeutic Targets(2023)10.1080/14728222.2023.2293757

N/A

0DataRank · unranked

19 citations

Reuben Ben‐David, Reza Mehrazin, Wei Yang, Ashutosh Tewari, Natasha Kyprianou +1 more

Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment

The Journal of Experimental Medicine(2024)10.1084/jem.20240045

N/A

0DataRank · unranked

25 citations

D. Youssef, Sanjana Shroff, Disha Chowhan, Kristin G. Beaumont, Robert Sebra +9 more

Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease

Cell Communication and Signaling(2021)10.1186/s12964-021-00755-6

N/A

0DataRank · unranked

37 citations

Navneet Dogra, Zach Dovey, Teja Ganta, Hee‐Seong Jang, Johnathan A. Khusid +20 more